There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with
a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 …

Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …

Obesity, characterized by chronic low-grade inflammation of the adipose tissue, is
associated with adverse coronavirus disease 2019 (COVID-19) outcomes, yet the …

COVID-19 shares the feature of autoantibody production with systemic autoimmune
diseases. In order to understand the role of these immune globulins in the pathogenesis of …

Background: Some data suggest a higher incidence of diagnosis of autoimmune
inflammatory rheumatic diseases (AIRDs) among patients with a history of COVID-19 …

Background A growing number of long COVID cases after infection have been reported. By
definition, long COVID is the condition whereby affected individuals do not recover for …

Some patients experience pulmonary sequelae after SARS-CoV-2 infection, ranging from
self-limited abnormalities to major lung diseases. Morphological analysis of lung tissue may …

COVID-19 is associated with neurological complications including stroke, delirium and
encephalitis. Furthermore, a post-viral syndrome dominated by neuropsychiatric symptoms …